March 1, 2010

Compliance demands continue to intensify for healthcare industry manufacturers. With top FDA administrators promising more executive accountability and more serious financial penalties, NAI’s March 2010 publication in MD&DI Magazine proposes that manufacturers recognize @BeginLink@The Need for Compliance as Business Strategy@EndLink@.

According to authors Stephen E. Rothenberg, J.D., Business Analyst, Michael N. Abrams, Managing Partner, and Rita E. Numerof, Ph.D., President, manufacturers should seize the issue, using compliance as a differentiator, and even to enhance relationships with physicians. They outline the business case for doing so, and proven techniques for integrating accountability for compliance into roles across the organization.